Publicaciones en las que colabora con Juan Antonio Díaz González (22)

2020

  1. Design and implementation of a teaching project for the formation of medical identity in medical students

    Educacion Medica, Vol. 21, Núm. 3, pp. 207-211

2016

  1. Role of histological regression grade after two neoadjuvant approaches with or without radiotherapy in locally advanced gastric cancer

    British Journal of Cancer, Vol. 115, Núm. 6, pp. 655-663

2012

  1. Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: A validation phase II trial

    International Journal of Radiation Oncology Biology Physics, Vol. 83, Núm. 2, pp. 587-593

2011

  1. Morbidity, mortality, and pathological response in patients with gastric cancer preoperatively treated with chemotherapy or chemoradiotherapy

    Journal of Surgical Oncology, Vol. 104, Núm. 2, pp. 124-129

  2. Patterns of response after preoperative intensity-modulated radiation therapy and capecitabine/oxaliplatin in rectal cancer: Is there still a place for ecoendoscopic ultrasound?

    International Journal of Radiation Oncology Biology Physics, Vol. 81, Núm. 2, pp. 439-444

  3. Patterns of response after preoperative treatment in gastric cancer

    International Journal of Radiation Oncology Biology Physics, Vol. 80, Núm. 3, pp. 698-704

  4. Transthoracic oesophagectomy with lymphadenectomy in 100 oesophageal cancer patients. Multidisciplinary approach

    Clinical and Translational Oncology, Vol. 13, Núm. 12, pp. 899-903

2009

  1. microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells

    Clinical Cancer Research, Vol. 15, Núm. 7, pp. 2281-2290

2008

  1. Phase I-II Trial of Concurrent Capecitabine and Oxaliplatin With Preoperative Intensity-Modulated Radiotherapy in Patients With Locally Advanced Rectal Cancer

    International Journal of Radiation Oncology Biology Physics, Vol. 71, Núm. 3, pp. 748-755

  2. cT3N0 rectal cancer: Potential overtreatment with preoperative chemoradiotherapy is warranted

    Journal of Clinical Oncology, Vol. 26, Núm. 3, pp. 368-373

2007

  1. Analysis of early postoperative morbidity among patients with rectal cancer treated with and without neoadjuvant chemoradiotherapy

    Annals of Surgical Oncology, Vol. 14, Núm. 5, pp. 1744-1751

  2. Rectal cancer treatment: Improving the picture

    World Journal of Gastroenterology, Vol. 13, Núm. 44, pp. 5805-5812

2006

  1. Improved incidence of pT0 downstaged surgical specimens in locally advanced rectal cancer (LARC) treated with induction oxaliplatin plus 5-fluorouracil and preoperative chemoradiation

    Annals of Oncology, Vol. 17, Núm. 7, pp. 1103-1110

  2. Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation

    International Journal of Radiation Oncology Biology Physics, Vol. 64, Núm. 4, pp. 1122-1128

2005

  1. Preoperative chemoradiation with oral tegafur within a multidisciplinary therapeutic approach in patients with T3-4 rectal cancer

    International Journal of Radiation Oncology Biology Physics, Vol. 61, Núm. 5, pp. 1378-1384

  2. Role of von Willebrand factor levels in the prognosis of stage IV colorectal cancer: Do we have enough evidence?

    World Journal of Gastroenterology

2003

  1. Radioterapia antiálgica: indicaciones clínicas y resultados

    Dolor y cáncer: hacia una oncología sin dolor (Madrid : Médica Panamericana, 2003), pp. 281-296

  2. Radioterapia en cáncer de recto localmente avanzado: situación actual y desarrollo terapéutico

    Revista de medicina, Vol. 47, Núm. 1, pp. 56-63

2002

  1. Ano-rectal sphincter preservation following preoperative chemoradiation in cT3-4Nx rectal cancer: Influence of tumor distance and downstaging

    Clinical and Translational Oncology, Vol. 4, Núm. 3, pp. 146-153

  2. Comparison of unidimensional and bidimensional measurements in metastatic non-small cell lung cancer

    British Journal of Cancer, Vol. 87, Núm. 2, pp. 158-160